Stock Events

Stock Events

Search...

Ovid Therapeutics (OVID) Q4 2024 Earnings

12NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.22

-0.11

0.01

0.12

Details

Expected EPS

-0.206529

Actual EPS

-0.2

Surprise EPS

0.01

Surprise Percent

+3.16%

Description

Ovid Therapeutics (OVID) has reported earnings of -0.2 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.